Literature DB >> 25108272

Corticosteroid use is associated with a reduced incidence of Clostridium difficile-associated diarrhea: a retrospective cohort study.

Amy L Wojciechowski1, Ganapathi I Parameswaran2, Arun Mattappallil3, Kari A Mergenhagen4.   

Abstract

The impact of corticosteroid use on the incidence of Clostridium difficile-associated diarrhea (CDAD) was examined retrospectively in 532 patients receiving antibiotic treatment for respiratory infections. As determined by logistic regression, corticosteroids were associated with a decreased incidence of CDAD (Odds Ratio 0.12, 95% Confidence Interval 0.006-0.95). Published by Elsevier Ltd.

Entities:  

Keywords:  Clostridium difficile; Enterocolitis; Glucocorticoids; Prevention & control; Pseudomembranous

Mesh：

Substances：

Year:  2014        PMID： 25108272     DOI： 10.1016/j.anaerobe.2014.07.010

Source DB:  PubMed          Journal:  Anaerobe        ISSN： 1075-9964            Impact factor:   3.331


  3 in total

1.  Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.

Authors:  Luis Furuya-Kanamori; Thomas V Riley; David L Paterson; Niki F Foster; Charlotte A Huber; Stacey Hong; Tiffany Harris-Brown; Jenny Robson; Archie C A Clements
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

2.  Lack of Association Between the Clinical Outcome of Clostridium difficile Infection and Current Steroids Use.

Authors:  Ahmed Dirweesh; Chikezie Alvarez; Muhammad Khan; Bushra Ambreen; Rishitha Yelisetti; Shaikh Fawwad Hamiz; Sana Zia; Muhammad Tahir; Vincent A DeBari; Donald Christmas; Sara Wallach
Journal:  Gastroenterology Res       Date:  2017-04-19

3.  Corticosteroids Do Not Increase the Likelihood of Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use.

Authors:  Travis J Carlson; Anne J Gonzales-Luna; Melissa F Wilcox; Sarah G Theriault; Faris S Alnezary; Pankaj Patel; Bumhee K Ahn; Evan J Zasowski; Kevin W Garey
Journal:  Open Forum Infect Dis       Date:  2021-08-11       Impact factor: 3.835
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.